Dr Holly Barker
Honorary (Fellow)
Department of Medical Biology (WEHI)
42 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcoma
DOI: 10.1186/s13046-025-03629-82025
Journal article
Genomics of cervical, vulvar and vaginal cancers and the potential of precision medicine
DOI: 10.1177/175883592513634992025
Journal article
Genomics of ovarian cancers and the potential of precision medicine
DOI: 10.1177/175883592513966512025
Journal article
Genomics of uterine malignancies and the potential of precision medicine
DOI: 10.1177/175883592513873952024
Journal article
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
DOI: 10.1186/s12943-024-02048-12024
Journal article
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and CCNE1 amplified ovarian cancer
DOI: 10.1016/j.isci.2024.1099782017
Journal article
Secondary somatic mutations restoring RAD51C and RAD51D associated with acquired resistance to the PARP inhibitor rucaparib in high-grade ovarian carcinoma
DOI: 10.1158/2159-8290.CD-17-0419
RECENT SCHOLARLY WORKS
2024
Journal article
A risk-reward examination of sample multiplexing reagents for single cell RNA-Seq
DOI: 10.1016/j.ygeno.2024.1107932023
Journal article
Targeting homologous recombination deficiency in uterine leiomyosarcoma
DOI: 10.1186/s13046-023-02687-02023
Journal article
A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review
DOI: 10.3390/cancers151743782023
Journal article
SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response
DOI: 10.1038/s41588-023-01460-5